Ustekinumab Induces Fast Response and Maintenance of Very Severe Refractory Scalp Psoriasis: Results in Two Greek Patients from the Psoriasis Hospital-Based Clinic

Publisher： Karger

E-ISSN： 1421-9832|228|2|107-111

ISSN： 1018-8665

Source： Dermatology, Vol.228, Iss.2, 2014-02, pp. : 107-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pregnancy during Ustekinumab Treatment for Severe Psoriasis

By  

Dermatology, Vol. 231, Iss. 2, 2015-03 ,pp. : 103-104

Karger

Access to resources Recommend Favorite

Response of Severe Psoriasis to Infliximab

By  

Dermatology, Vol. 204, Iss. 2, 2002-04 ,pp. : 156-157

Karger

Access to resources Recommend Favorite

Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 230, Iss. 1, 2015-01 ,pp. : 46-54

Karger

Access to resources Recommend Favorite

Efficacy of Ustekinumab in Palmoplantar Psoriasis

By  

Dermatology, Vol. 221, Iss. 4, 2010-10 ,pp. : 321-323

Karger

Access to resources Recommend Favorite

Psoriasis Comorbidities: Results from the National Psoriasis Foundation Surveys 2003 to 2011

By  

Dermatology, Vol. 225, Iss. 2, 2012-10 ,pp. : 121-126

Karger

Access to resources Recommend Favorite